Dapaglifozin in advanced heart failure patients : effects on congestion, NTproBNP and cardiorenal outcome

11 May 2024 (11:17 - 12:25)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Gaetano Ruocco

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

5 More presentations in this session

Presentation thumbnail

Decline in functional capacity is associated with reduced ability to perform activities of daily living in patients with transthyretin cardiac amyloidosis: post hoc analysis of the APOLLO-B study

Doctor O. Lairez (Toulouse, FR)

Abstract Slides Video

Presentation thumbnail

Navigating the realms of SGLT2 inhibitors bridging clinical studies enthusiasm with practical realities

Doctor M. ElRefai (Basildon, GB)

Abstract Slides Video

Presentation thumbnail

Heart rate management practices across the spectrum of HFrEF patient journey in Indian clinical settings

Doctor V. Kolapkar (Thane, IN)

Abstract Slides Video

Presentation thumbnail

Age-related implications in guideline-directed medical therapy up-titration for heart failure with reduced ejection fraction

Doctor C. Gregorio (Lisbon, PT) Doctor J. Cravo (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Home intravenous diuretics: a way to reduce hospital bed usage and urgent admissions

Doctor M. Castro (Guimaraes, PT)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy 1

The Event

Event poster

Heart Failure 2024

11 May 2024 11:17 CET

You may be interested in

Congress Presentation

Dapagliflozin effect on cardiopulmonary function, reverse cardiac remodelling and biomarkers in a cohort of HFrEF patients

Congress Session

Further Insights into SGLT2i treatment for heart failure

Congress Session

Medical treatment in acute heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources